OraSure Seeks Panel Feedback On Marketing Of Home-Use HIV Test
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies will seek guidance from FDA's Blood Product's Advisory Committee on making its OraQuick Advance oral HIV test available over the counter for use in the home